thiosulfates has been researched along with Obesity in 9 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of calciphylaxis in a patient with normal renal function and hypoparathyroidism, who responded to treatment with sodium thiosulfate." | 3.75 | Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate. ( Hackett, BC; McAleer, MA; O'Donnell, BF; Powell, FC; Sheehan, G, 2009) |
| "Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific literature many decades ago." | 2.52 | Calciphylaxis: risk factors, diagnosis, and treatment. ( Goverman, J; Jackson, VA; Kamdar, MM; Kroshinsky, D; Malhotra, R; Nazarian, RM; Nigwekar, SU; Steele, DJ; Thadhani, RI, 2015) |
| "Calciphylaxis is a very uncommon and severe disease which mainly appears in patients with chronic renal insufficiency." | 2.43 | Calciphylaxis: no therapeutic concepts for a poorly understood syndrome? ( Gille, J; Kaufmann, R; Meissner, M, 2006) |
| "Calciphylaxis is associated with a high mortality rate." | 1.43 | Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis. ( Albright, RC; Bridges, AD; Claus, PL; Davis, MD; Dillon, JJ; El-Azhary, RA; El-Zoghby, ZM; Hickson, LJ; Kumar, R; McBane, RD; McCarthy, JT; McCarthy-Fruin, KA; McEvoy, MT; Patzelt, MT; Pittelkow, MR; Weaver, AL; Wetter, DA; Williams, AW, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia, CP | 1 |
| Roson, E | 1 |
| Peon, G | 1 |
| Abalde, MT | 1 |
| De La Torre, C | 1 |
| Nigwekar, SU | 1 |
| Kroshinsky, D | 1 |
| Nazarian, RM | 1 |
| Goverman, J | 1 |
| Malhotra, R | 1 |
| Jackson, VA | 1 |
| Kamdar, MM | 1 |
| Steele, DJ | 1 |
| Thadhani, RI | 1 |
| McCarthy, JT | 1 |
| El-Azhary, RA | 1 |
| Patzelt, MT | 1 |
| Weaver, AL | 1 |
| Albright, RC | 1 |
| Bridges, AD | 1 |
| Claus, PL | 1 |
| Davis, MD | 1 |
| Dillon, JJ | 1 |
| El-Zoghby, ZM | 1 |
| Hickson, LJ | 1 |
| Kumar, R | 1 |
| McBane, RD | 1 |
| McCarthy-Fruin, KA | 1 |
| McEvoy, MT | 1 |
| Pittelkow, MR | 1 |
| Wetter, DA | 1 |
| Williams, AW | 1 |
| Hackett, BC | 1 |
| McAleer, MA | 1 |
| Sheehan, G | 1 |
| Powell, FC | 1 |
| O'Donnell, BF | 1 |
| Scola, N | 1 |
| Kreuter, A | 1 |
| Meissner, M | 1 |
| Gille, J | 1 |
| Kaufmann, R | 1 |
| Köstler, E | 1 |
| Wollina, U | 1 |
| Rudali, G | 1 |
| Silberman, C | 1 |
| Soyka, LF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Partners Calciphylaxis Biobank and Patient Registry[NCT03032835] | 300 participants (Anticipated) | Observational [Patient Registry] | 2017-01-31 | Recruiting | |||
| Effects of Human Amniotic Mesenchymal Stem Cells (hAMSCs) on Wound Healing in Uremic Calciphylaxis Patients: an Open Label Single Arm Study[NCT04592640] | 7 participants (Anticipated) | Interventional | 2018-09-17 | Active, not recruiting | |||
| European Calciphylaxis Registry Network[NCT02635373] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2015-12-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for thiosulfates and Obesity
| Article | Year |
|---|---|
Calciphylaxis: risk factors, diagnosis, and treatment.
Topics: Animals; Arterioles; Biopsy; Calciphylaxis; Case-Control Studies; Chronic Kidney Disease-Mineral and | 2015 |
Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbar | 2006 |
7 other studies available for thiosulfates and Obesity
| Article | Year |
|---|---|
Calciphylaxis treated with sodium thiosulfate: report of two cases.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Atrial Fibrillation; Calciphylaxis; Comorbidity; Diabetes Me | 2013 |
Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis.
Topics: Adult; Aged; Aged, 80 and over; Calciphylaxis; Debridement; Diabetes Mellitus; Female; Glomerular Fi | 2016 |
Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate.
Topics: Abdominal Wall; Adult; Anticoagulants; Calciphylaxis; Calcium; Chelating Agents; Female; Humans; Hyp | 2009 |
Calciphylaxis: a severe complication of renal disease.
Topics: Adrenal Cortex Hormones; Calciphylaxis; Chelating Agents; Cinacalcet; Humans; Ischemia; Kidney Failu | 2011 |
[Reader's letter on Marcus Meissner, Jens, Gille, Roland Kaufmann. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?].
Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbar | 2007 |
[Study of some endocrine reactions accompanying obesity induced in AkR mice by gold thioglucose].
Topics: Animals; Female; Glucose; Male; Obesity; Pregnancy; Rats; Reproduction; Thiosulfates | 1966 |
Enhancement of goldthioglucose toxicity and obesity by concurrent glucose administration.
Topics: Animals; Glucose; Gold; Male; Mice; Obesity; Thiomalates; Thiosulfates | 1966 |